Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response

SIMPLE SUMMARY: Immunotherapy targeting immune checkpoint pathways have recently attracted great attention in cancer treatment, but better strategies are needed to identify patients likely to benefit from it. The major histocompatibility complex (MHC) class I expression in cancer cells greatly influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosca, Laura, de Angelis, Alessandra, Ronchi, Andrea, De Chiara, Annarosaria, Fazioli, Flavio, Ruosi, Carlo, Altucci, Lucia, Conte, Mariarosaria, de Nigris, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322060/
https://www.ncbi.nlm.nih.gov/pubmed/35884474
http://dx.doi.org/10.3390/cancers14143414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322060/
https://www.ncbi.nlm.nih.gov/pubmed/35884474
http://dx.doi.org/10.3390/cancers14143414

Ejemplares similares